Cargando…
Effect of Clinically Uninfected Orthopedic Implants and Pacemakers/AICDs in Low-Risk Staphylococcus aureus Bloodstream Infection on Crude Mortality Rate: A Post Hoc Analysis of a Large Cohort Study
BACKGROUND: The standard treatment duration in low-risk Staphylococcus aureus bloodstream (SAB) is 14 days. However, it is unclear whether an extended course of antimicrobial therapy is necessary in patients with clinically uninfected prosthetic joints/osteosyntheses or pacemakers/automated implante...
Autores principales: | Kaasch, Achim J, Kern, Winfried V, Joost, Insa, Hellmich, Martin, Seifert, Harald, Rieg, Siegbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521783/ https://www.ncbi.nlm.nih.gov/pubmed/31111077 http://dx.doi.org/10.1093/ofid/ofz170 |
Ejemplares similares
-
Protocol update for the SABATO trial: a randomized controlled trial to assess early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection
por: Kaasch, Achim J., et al.
Publicado: (2020) -
Early oral switch therapy in low-risk Staphylococcus aureus bloodstream infection (SABATO): study protocol for a randomized controlled trial
por: Kaasch, Achim J., et al.
Publicado: (2015) -
Microarray-Based Genotyping and Clinical Outcomes of Staphylococcus aureus Bloodstream Infection: An Exploratory Study
por: Rieg, Siegbert, et al.
Publicado: (2013) -
Staphylococcus aureus bacteremia with iliac artery endarteritis in a patient receiving ustekinumab
por: Joost, Insa, et al.
Publicado: (2016) -
A Single-Center Prospective Cohort Study on Postsplenectomy Sepsis and its Prevention
por: Rieg, Siegbert, et al.
Publicado: (2020)